No profile data available.
The Oncology Institute, Inc. (TOI) is a healthcare company in the focused walk-in medical services industry, based in Cerritos, United States, with about 641 full-time employees.
It reported revenue of $502.73 million for fiscal year 2025, up 27.8% from fiscal year 2024, and net income of -$50.31 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $161.28 million, up 34.6% from a year before. Its largest business segment, Specialty Pharmacy, brought in 54% of segment revenue in fiscal year 2025. Its market capitalization was $512.91 million.
Figures from company filings and market data; latest fiscal year ended December 31, 2025.
, an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Oncology Institute reported $502.73 million in revenue for fiscal year 2025, up 27.8% from $393.41 million in fiscal year 2024. In Q2 2026 revenue was $161.28 million.
Specialty Pharmacy, with $269.18 million or 54% of segment revenue in fiscal year 2025. Next: Patient Services (46%) and Clinical Trials & Other (1%).
$512.91 million.
Listed companies of a similar size in the same industry (focused walk-in medical services) include Clínica Baviera, S.a. (CBAV.MC), Euroeyes (1846.HK), Q & M Dental Group (Singapore) Limited (QC7.SI), KT Medical Service Public Company Limited (KTMS.BK).